ArticleEye (London, England)2026
Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study was to report results of a survey on the diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes and identify future research priorities.
methodsWe conducted a survey among the members of the European Glaucoma Society to explore their perspectives on the most critical questions regarding glaucoma in myopic eyes. We asked participants to compose critical questions about glaucoma diagnostics, progression monitoring, nonsurgical, and surgical management in myopic eyes. We used large language models to identify the most frequently recurring themes in the questions and human evaluation to validate and calculate responses for each theme.
resultsA total of 251 participants out of 1045 responded, of whom 98% were glaucoma specialists, and 86% glaucoma surgeons. We received 581 questions on diagnostics, 470 on progression monitoring, 453 on nonsurgical treatment, and 483 on surgical treatment of glaucoma in myopic eyes. The top themes for diagnostics and progression monitoring were differentiating glaucomatous changes and progression from myopic changes and progression, role and reliability of ocular coherence tomography, and visual field testing and interpretation in myopic eyes. For treatment, the leading themes were choice of surgical procedure, effectiveness of different medications, and effectiveness of selective laser trabeculoplasty in the treatment of glaucoma in myopic eyes.
conclusionsThe survey showed that there are knowledge gaps regarding diagnostics, monitoring, and treatment of glaucoma in myopic eyes among glaucoma experts. We recommend that the most frequently recurring themes of this survey are prioritised in future research in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.